[Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 32, Issue 11, 2010, Pages 864-867

  Wang, Yan ^a   Li, Jun jie ^b   DI, Gen hong ^b   Lu, Jing song ^b   Wu, Jiong ^b   Liu, Guang yu ^b   Hu, Xi chun ^b   Wang, Zhong hua ^b   Yang, Wen tao ^b   Shao, Zhi min ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PACLITAXEL; TAXANE; TAXOID; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; ANTHRACYCLINES; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BRIDGED COMPOUNDS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS; TREATMENT FAILURE;

EID: 84879243840     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)